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Intro: Telemedicine has offset disruptions to outpatient chronic disease care during the COVID-
19 pandemic. Studies have shown decreased video telemedicine engagement among patients of 
Black race, Hispanic ethnicity, older age, and with public insurance. We assessed if similar 
patterns were seen among providers who predominantly adopted video telemedicine during the 
COVID-19 pandemic. 
 
Methods: A single-center longitudinal study of cardiovascular patients from March 16-October 
31, 2020 was performed to study trends in video visit volume, variation in provider use of video 
visits, and identify predictors of video (vs. phone) visits using descriptive statistics and 
multivariable logistic regression. 
 
Results: A total of 18,950 patients were studied with 51% having at least 1 video visit. Video visit 
volume rapidly increased from March to June 2020, where it accounted for 42% of all patient 
encounters. Large variation in the use of video visits among providers was observed with mean 
(standard deviation) use of 44% (±29). Among patients of high-video-use providers, lower video 
use was observed among patients of Black race, Hispanic ethnicity, older age, and those with 
public insurance and an activated MyChart account in descriptive statistics and multivariable 
adjustment. After adjusting for patient characteristics, patients with a high-video-use provider 
were 9.35 (95% confidence interval, 8.43-10.39) times as likely to have a video visit compared to 
patients of low-video-use providers. Patients without an activated MyChart were 0.33 (95% CI, 
0.31-0.36) times as likely to have a video visit. Only 47% of patients of Black race had an activated 
MyChart vs. 66% of White patients (P<.001).  
 
Discussion: Video telemedicine care has rapidly expanded during the COVID-19 pandemic with 
growing engagement among providers. We find that even among providers with high video 
adoption, the digital access divide persisted. Ensuring equitable access of telemedicine 
technology is crucial to reducing disparities as virtual care becomes more commonly integrated 
into modern healthcare. Increasing the use of MyChart, a patient portal with video telemedicine 
capabilities, among low video groups may improve accessibility. Other systemic approaches will 
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Telemedicine has offset disruptions to outpatient care during the coronavirus disease 2019 
(COVID-19) pandemic1,2. Aided by federal regulatory provisions3-5, phone and video-based virtual 
visit programs rapidly expanded in March 2020 to decrease transmission of SARS-CoV-2 among 
at-risk patients and providers.  
Short-term studies have found dynamic trends in the use of video and phone (audio-only) 
telemedicine vs. in-person visits1,2,6 and have identified decreased engagement with video visits 
among patients of Black race, Hispanic ethnicity, older age, and with public insurance7-9. While it 
is unclear if video visits are clinically superior to phone visits, video visits offer capabilities for 
providers to visually assess their patients, show patient radiologic images or lab results, and 
communicate non-verbally, among other advantages8. Additionally, patient subgroups with 
reduced video engagement also have, on average, poorer baseline healthcare access and 
outcomes compared to reference groups. The digital divide between patients who experience the 
full benefits of video telemedicine and those who do not may widen existing disparities in care 
and outcomes.  
Identifying opportunities for interventions to decrease this digital divide is important for the 
long-term success of telemedicine. Provider use of video may be variable as providers have 
varying attitudes toward video telemedicine care10. Accordingly, we sought to determine how 
variable video use was among providers and if lower video use in certain subgroups was 
alleviated among patients of providers who predominantly adopted video visits into their 




Study Population  
 We included all patients with telemedicine visits between March 16th-October 31st, 2020 
March 16th-October 31st, 2020 with providers at the Massachusetts General Hospital (MGH) 
Corrigan Minehan Heart Center. The study period began one week prior to Massachusetts’ stay-
at-home order issued on March 24, 202011 and our institution’s policy change to see patients 
virtually when possible. The study ended several months after our institution permitted in-person 
and hybrid care in August 2020. MGH’s catchment area includes the New England area with most 
patients residing in Massachusetts. Patients with only research visits (n=17) were excluded.  
Study Measures 
We abstracted patient and visit information from the center’s administrative database. 
Data included each visit type (phone, video, in-person), patients’ date of visit(s), age, sex, self-
reported race (White, Black, Asian, or other) and ethnicity (non-Hispanic, or Hispanic), insurance 
payor (private, public, or none), residential ZIP code, MyChart activation status—MGH’s online 
patient portal—and the clinician who conducted each visit. Residential ZIP codes were classified 
as urban or suburban-rural using the U.S. Department of Agriculture’s Rural-Urban Commuting 
Area Codes12. Rural and suburban ZIP codes were combined due to small sample sizes in each. 
Cardiovascular disease (CVD) history was ascertained from up to four diagnostic codes 
(International Classification of Disease, Tenth Revision, ICD-10) based on conventional grouping 
of common CVDs (Appendix A).  
Missing data was uncommon for most variables. Race was missing for 3% of patients and 
ethnicity was missing for 9% of patients, and these missing values appeared to be missing at 
random. To address possible bias, we report these variables with missing data as a “missing” 
category in the descriptive statistics. Missing values were not imputed. Visit type was missing for 
1.4% of visits, so these observations were excluded from analysis. We report false discovery rate-
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adjusted P-values to account for multiple comparisons with a P-value of <.05 considered 
statistically significant.  
Analysis 
 Trends in visit types were plotted and tested for linearity using two-sided Cochran-
Armitage tests. To calculate these trends, in-person visits were included. All subsequent analyses 
discussed below only included telemedicine (phone, video) visits.  
To determine the variation in the use of video among providers, median and interquartile 
ranges of provider video use among telemedicine visits was calculated. We tested for trend using 
a simple median regression using each month to predict changes in the proportion of video visits 
conducted by provider.  
Providers in the upper quintile of video visit use (number of video visits among total 
telemedicine visits) were classified as high-video-use providers; all other clinicians were classified 
as low-video-use providers. Quintiles were determined using Jenk’s natural breaks optimization, 
a method which minimizes each quantile’s mean deviation from the quantile mean and maximizes 
each quantile’s deviation from other quantile’s means.13  
At the patient-level, the outcome was ever video vs. phone only telemedicine visits across 
the study period. Patient characteristics were compared by provider video-use level and outcome 
using Chi-square and Wilcoxon rank-sum tests. To identify predictors of ever video (vs. phone) 
visits among patients, we calculated a multivariable logistic model controlling for patients’ age, 
sex, insurance, race and ethnicity (self-reported), residence type (urban vs. suburban-rural) by 
ZIP code, activation of MyChart, and provider video-use-level (high vs. low).   
All analyses were conducted using R (Version 1.4)14. CG conducted and takes full 
responsibility for all analyses. Code is available upon request. The Mass General Brigham and 





Trends in visit volume 
Our center’s 169 providers conducted 33,650 visits for 24,562 patients. Telemedicine 
visits accounted for 73% of visits (24,470/33,650) of which 48% were video visits and 52% were 
by phone and conducted for 18,950 patients. Phone visits rapidly increased from mid-March to 
early April (P<.001), first peaking at 580 visits in the week of April 12th, 2020 accounting for 83% 
of all visits that week. Phone visits then steadily declined through the study period (P<.001) 
accounting for 21% of all visits in the last week in October. Video visits also quickly increased in 
use (P<.001), albeit less quickly than phone visits, first peaking the week of May 17th, 2020 with 
458 visits (42% of all visits that week). Video visits gradually increased through the study period 
(P<.001) accounting for 34% of all visits during the last week of October 2020. In-person visits 
abruptly decreased just prior to the study start and remained low through early June 2020, 
accounting for <5% of all weekly visits during this period. These visits subsequently increased 
through the study period (P<.001), peaking the week of September 20th, 2020 accounting for 46% 
of all visits that week.   
Trends in provider variation of video visit use 
There was large variation in the use of video visits among providers with a mean use of 
44% (standard deviation= ±29%). Variation in video use, measured by interquartile range (IQR), 
was largest in June 2020 (46% [IQR=16%-75%]) and persisted throughout the study period 
(October: 64% [36%-84%]) (Figure 2). Despite this large variation, each subsequent month was 
associated with a 7.6% increase in median video use (standard error=0.008, P<.001).  
Patient outcome: ever video vs. phone telemedicine visit 
A total of 24,470 telemedicine visits for 18,950 patients were conducted during the study 
period. Most patients (79%, n=14940) had one visit, 16% (n=2990) had two visits, and 5% 
(n=1020) had three or more visits. A slight majority of patients had at least one video visit (51%, 
n=9575) with the remaining having only phone telemedicine visits (49%, n=9375). The mean (sd) 
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age of patients with an ever video visit was 62 (±16) whereas the mean age of phone-only patients 
was 70 (±14) (P<.001) (Table 1). Among White patients, 51% had a video visit vs. 41% of Black 
patients, and among non-Hispanic patients, 51% had a video visit vs. 38% of Hispanic patients 
(both P<.001). Patients with private insurance more often had a video visit (61%) vs. those with 
public insurance (42%) (P<.001) as well as patients living in suburban-rural ZIP codes (56%) vs. 
those in urban ZIP codes (50%) (P<.01). Differences in video use were also observed by patient’s 
primary cardiovascular disease diagnosis with 68% of patients with congenital heart disease 
having a video visit (P<.001) compared with 46% of patients with coronary artery disease 
(P<.001), 41% with heart failure (P<.001), 45% with hypertension (P<.001), and 48% with 
hyperlipidemia (P<.001). Patients with more visits during the study period more often had at least 
one video visit with 71% of patients with 3+ visits having a video visit (P<.001). No difference was 
observed by sex or stroke diagnosis.  
 Patient video use by provide video-use level 
Thirty-three clinicians (24%) were high-video-use providers, conducting 70% or more of 
their visits via video. High-video-use providers saw 4,228 patients during 5,084 telemedicine visits 
with a mean video use of 87% (±10%). Low-video-use providers (n=136) had a mean video use 
of 34% (±22%) seeing 14,722 patients during 19,386 telemedicine visits.  
Patient demographics differed between provider video-use level and outcome with 86% 
of patients among high-video-use providers having one or more video visits compared to 40% of 
low-video-use provider patients (Table 2). High-video-use providers saw more female and White 
patients with private insurance and an activated MyChart (all P<.01). Among high-video-use 
provider patients, 78% of Black patients engaged in a video visit compared to 86% of White 
patients (P<.001), 74% of Hispanic patients were seen on video compared to 86% of non-Hispanic 
patients (P<.001), and 91% of patients with private insurance had a video visit compared to 79% 
of patients with public insurance (P<.001). Patients with a video visit were younger (P<.001) and 
more often had an activated MyChart (91% vs. 76% without an activated account, P<.001). Similar 
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patterns were seen among low-video-use provider patients except for male patients and suburban 
or rural patients having greater video use. After controlling for patient characteristics, high-video-
use provider patients were 9.4 (95% CI, 8.4-10.4) times as likely to have a video visit compared 
to low-video-use provider patients (Table 3).  
Post hoc analysis: MyChart activation status 
As patients without an activated MyChart were 0.33 (95% CI,  0.31-0.36) times as likely 
to have a video visit (Table 3), we stratified our sample by patients’ MyChart activation status. 
Sixty-four percent (12136/18950) of patients with a telemedicine visit had an activated MyChart. 
Among this group, 75% had at least one video visit compared to 25% of patients without an 
activated MyChart (P<.001) (Table 5). Patients demographics associated with higher MyChart 
activation included 66% of female patients vs. 63% of male patients (P<.001), 66% of White 
patients vs. 47% of Black and 45% of other race patients (P<.001), 65% of non-Hispanic patients 
vs. 40% of Hispanic patients (P<.001), and 68% of patients with private insurance vs. 60% with 
public or no insurance (P<.001). Additionally, 64% of urban-residing patients had an activated 

























In this longitudinal study of 24,470 telemedicine visits among 18,950 patients during the 
COVID-19 pandemic, video visit volume rapidly increased from March to June 2020 and remained 
in frequent use through October 2020. We observed increasing use of video visits among 169 
providers, with observed variability across providers with a mean video use of 44% (±29). Patient 
subgroups with decreased video engagement included patients of Black race, Hispanic ethnicity, 
older age, and with public insurance. We found that these subgroups had lower video 
engagement even among high-video-use providers. MyChart activation was a strong predictor of 
video use, and activation was low among patients of Black race (47%) and Hispanic ethnicity 
(40%) compared to White (66%) and non-Hispanic patients (65%).  
Lower video engagement among these subgroups has been identified in other studies during 
the COVID-19 pandemic7,8. Our study adds that even among providers who largely adopted video 
visits into their telemedicine practice, Black, Hispanic, older, and public insurance patients still 
had lower video engagement. Suboptimal video engagement may not be surmountable by 
increased provider adoption of telemedicine alone. Patients with an activated MyChart were more 
likely to engage in video visits, and patients of Black race and Hispanic ethnicity had low rates of 
MyChart activation compared to White and non-Hispanic patients. MyChart offers video 
teleconferencing capabilities which providers at our institution frequently used to conduct video 
visits, in addition to other teleconferencing platforms. MyChart activation may be a proxy measure 
of digital literacy in this sample.  
Reasons underlying inequities in telemedicine should be better understood at the local level 
to inform intentional interventions to increase telemedicine access and reduce inequities. 
Inadequate telecommunication infrastructure, poor patient digital literacy, lack of provider training, 
and patient or provider preference likely all play a role in unequal video visit use. Because of the 
identified association between MyChart activation and video visit use in this study, an important 
next step may be to identify barriers to patients accessing MyChart and enroll patients in MyChart 
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with a focus on Black and Hispanic patients. A recent presidential advisory from the American 
Heart Association and American Stroke Association called for investments in telemedicine 
infrastructure to increase access to broadband internet and to devices capable of video 
teleconferencing to alleviate inequities.15 For example, Boston has offered low-cost Wi-Fi 
hotspots16 to low-income residents during the pandemic. Training providers to use video and other 
telemedicine technologies and workflows may also increase video telemedicine use and lessen 
disparities15,17. Hospitals may consider establishing internal groups to measure telemedicine use 
and develop direct interventions for more equitable use18.  
The rapid utilization of telemedicine in a variety of specialties1,19-21 during the COVID-19 
pandemic may mark a paradigm shift in how healthcare is delivered and how physicians and 
patients interact22. The benefits of telemedicine-integrated care has been suggested as early as 
199523-25, yet implementation of telemedicine as a supplement or alternative to traditional, in-
person patient visits has been slow, albeit with increasing use in primary care and mental health 
services in 2016-201726. Video telecommunications have quickly evolved and are now common 
in U.S. households, yet people of older age, low income, and whom live in rural areas have lower 
use15,27,28.  
As telemedicine becomes more accessible and available from providers, certain populations 
may require intentional engagement and education to achieve equitable access29. Many clinical 
practices are currently developing robust infrastructure and targeting high volume video clinicians 
to lead efforts to address issues of equity. This study demonstrates that these mechanisms alone 
may not be adequate to alleviate existing disparities in access.  
Limitations 
 Limitations of this study include enrollment of patients from a single medical subspecialty, 
which may not be generalizable to other patient populations. However, lower video use among 
patients of Black race, older age, and public insurance have been observed across multiple 
medical specialties8. Generalizability to other regions may be limited as Massachusetts ranked 
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1st in the U.S. in the rate of telemedicine visits conducted from March through June 20202, yet we 
believe our sample of largely Massachusetts residents is especially relevant for the study of long-
term telemedicine trends and disparities. This study lacks important patient demographic data 
that may be associated with video use, such as internet access, ownership of a device capable 
of video teleconferencing, and measurements of social determinants of health. While we lack 
qualitative patient data on reasons for selecting a video or phone visit, a pre-COVID survey study 
among cardiovascular patients at MGH found that patients are highly satisfied with video 
telemedicine visits, especially for its convenience and reduced travel cost, suggesting that video 
visits could be a preference for patients in the future.30 The extent to which video visits are offered 
by the provider or requested by the patient is currently unclear. Nevertheless, by studying the 
utilization of telemedicine care, we offer insight into trends and disparities in engagement which 






























Our study finds that video telemedicine was rapidly adopted during the COVID-19 pandemic 
and remained in high use through October 2020 with growing engagement among providers. 
Telemedicine opens opportunities for patients to not only be safely cared for during public health 
emergencies, but also allows patients greater flexibility in managing their health with improved 
convenience, cost, and high-quality continuous care. Population subgroups that lag behind in 
video telemedicine use, even when their provider largely adopted video visits into their practice, 
will likely require intentional engagement to improve their telemedicine access. As telemedicine 
becomes more integrated into care delivery models beyond the current pandemic, identifying and 
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Figures and Tables 
 
Figure 1. Trends in visit volumes from March 16-October 31, 2020.  
 
 
Figure 2. Trends in the proportion of video visits among telemedicine visits conducted by each 
provider. Each month increase was associated with a 7.6% increase in median video use 



















































































Table 1: Patient demographic and clinical characteristics by outcome status a,b 




Age (mean ±sd) 62 (±16) 70 (±14) <.001 
Sex    
     Male 51% (5475) 49% (5343) .82 
     Female 50% (4100) 50% (4032)  
Race   <.001 
     White 51% (8520) 49% (8147)  
     Black 41% (233) 59% (331)  
     Asian 53% (318) 47% (278)  
     Other or Missing 45% (504) 55% (619)  
Ethnicity   <.001 
     Non-Hispanic 51% (8463) 49% (8187)  
     Hispanic 38% (229) 62% (375)  
     Other or Missing 52% (879) 48% (811)  
Payor   <.001 
     Private 61% (5301) 39% (3408)  
     Public 42% (4223) 58% (5930)  
     None 58% (51) 42% (37)  
MyChart    <.001 
     Activated 59% (7206) 41% (4930)  
     Not activated 35% (2369) 65% (4445)  
Residence   <.01 
     Urban 50% (9112) 50% (9010)  
     Suburban-Rural 56% (447) 44% (358)  
History of Major CVD     
     CHD 68% (724) 32% (342) <.001 
     CAD 46% (2647) 54% (3056) <.001 
     Heart Failure 41% (831) 59% (1196) <.001 
     Stroke 53% (138) 47% (124) .56 
     Hypertension 45% (3534) 55% (4384) <.001 
     Hyperlipidemia 48% (2256) 52% (2457) <.001 
Number of Visits   <.001 
     1 47% (6959) 53% (7981)  
     2 63% (1889) 37% (1101)  
     3+ 71% (727) 29% (293)  
 
Abbreviations: CVD, cardiovascular disease; CHD, congenital heart disease; CAD, coronary 
artery disease 
a Row percents (count) may not sum to 100% due to rounding. 
b !" and Student’s t-tests.  
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Table 2: Patient characteristics by provider video-use level and outcome a-c 









(n=8797) P-valuec  
High vs. low 
video-use P-valuec 
Age (mean ±sd) 60 (±17) 69 (±16) <.001  63 (±16) 70 (±14) <.001  -5.7 <.001 
Sex   .89    .02   <.001 
     Male 86% (1660) 14% (270)   41% (5037) 59% (3507)   -5% (-4460)  
     Female 86% (1475) 14% (243)   39% (2418) 61% (3760)   5% (-6614)  
Race   .02    <.001   <.01 
     White 86% (2815) 14% (443)   41% (5239) 59% (7643)   2% (-9624)  
     Black 78% (60) 22% (17)   35% (165) 65% (312)   -1% (-400)  
     Asian 88% (98) 11% (13)   44% (205) 56% (265)   <-1% (-359)  
     Other or Missing 80% (162) 20% (40)   35% (316) 65% (577)   <-1% (-691)  
Ethnicity   <.01    <.001   <.001 
     Non-Hispanic 86% (2711) 14% (440)   41% (5287) 59% (7684)   -2% (-9820)  
     Hispanic 74% (69) 26% (24)   30% (150) 70% (351)   <-1% (-408)  
     Other or Missing 88% (352) 12% (49)   39% (487) 61% (760)   3% (-846)  
Payor   <.001    <.001   <.001 
     Private 91% (1850) 8% (171)   50% (3215) 50% (3221)   12% (-4415)  
     Public 79% (1263) 21% (339)   32% (2683) 67% (5542)   -12% (-6623)  
     None 88% (22) 12% (3)   44% (27) 56% (34)   <1% (-36)  
MyChart    <.001    <.001   <.001 
     Activated 91% (2215) 9% (227)   50% (4619) 50% (4671)   4% (-6848)  
     Not activated 76% (920) 24% (286)   24% (1306) 76% (4126)   -4% (-4226)  
Residence   .89    .02   .20 
     Urban 86% (2984) 14% (489)   40% (5646) 60% (8457)   <-1% (-10629)  
     Suburban-Rural 86% (145) 14% (23)   45% (270) 55% (334)   <1% (-436)  
a 
Row percents (count) may not sum to 100% due to rounding. 
b 
580/18950 (3%) patients were seen by both types of providers and were excluded. 
c !" and Student’s t-tests.  
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Abbreviation: CI, confidence interval 
a  n=18370 for this model. 580 patients with visits with both high and low-video-use providers were 
excluded. 29 patients had missing ZIP codes.  
b Model was determined by stepwise backward selection based on minimizing the Akaike 
Information Criterion. Race groups were combined (White, Asian, Other), and ethnicity groups 
were combined (other was added to non-Hispanic) for model parsimony as the uncombined 





















 Ever video vs. phone only 
 OR 95% CI P-value 
Age (per year) 0.97 0.97-0.97 <.001 
Female sex 0.87 0.81-0.93 <.001 
Race    
     White, Asian, Other Ref - - 
     Black 0.74 0.61-0.90 <.01 
Ethnicity    
     Non-Hispanic Ref - - 
     Hispanic 0.57 0.46-0.69 <.001 
Payor    
     Private Ref - - 
     Public or None 0.73 0.68-0.79 <.001 
Residence    
     Urban Ref - - 
     Suburban or Rural 1.27 1.07-1.49 <.01 
MyChart    
     Activated Ref - - 
     Not activated 0.33 0.31-0.36 <.001 
Provider video-use     
     Low Ref - - 
     High 9.35 8.43-10.39 <.001 
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Age (per year) 65 (±15) 67 (±16) <.001 
Sex   <.001 
     Male 63% (6800) 37% (4018)  
     Female 66% (5336) 34% (2769)  
Race   <.001 
     White 66% (10982) 34% (5685)  
     Black 47% (266) 53% (298)  
     Asian 64% (383) 36% (213)  
     Other 45% (505) 55% (618)  
Ethnicity   <.001 
     Non-Hispanic 65% (11897) 35% (6443)  
     Hispanic 40% (239) 60% (365)  
Payor   <.001 
      Private 68% (5962) 32% (2747)  
 Public or None 60% (6174) 40% (4067)  
Residence   <.001 
     Urban 64% (11660) 36% (6462)  
     Suburban or Rural 57% (462) 43% (343)  
Telemedicine visit 
outcome 
  <.001 
     Ever video 75% (7206) 25% (2369)  
     Phone only 53% (4930) 47% (4445)  
Provider video-usec   <.001 
     Low 63% (9290) 37% (5432)  
     High 67% (2442) 33% (1206)  
a Row percents (count) may not sum to 100% due to rounding. 
b !" and Student’s t-tests.  





















Appendix A: Cardiovascular disease history groupings using the International Classification of 




















Abbreviation: ICD-10, International Classification of Diseases, 10th Revision 
Cardiovascular Disease ICD-10 
Atrial fibrillation I48 
Congenital heart disease Q20-Q26 
Coronary artery disease I21-I25 
Hypertension I10-I16 
Heart failure I50 
Stroke I63 
Hyperlipidemia E78.2 
E78.4 
E78.5 
E78.0 
